The European Parliament urged EU member countries to conduct research on the use of medical cannabis - and to create unified regulations for all member countries. The Parliament's press service reported that.
It is noted that several European countries allowed the use of certain kinds of cannabis or cannabinoids for medical purpose; some countries still consider opportunities for submitting changes to the legal framework.
However, the rules of use of cannabis strongly differ in various countries. No EU member country allows smoking or growing cannabis at home for medical purposes.
Due to these circumstances, the European Parliament calls for extra research on this topic. The respective resolution was approved on February 13. In it, the Parliament asks to provide a legal definition for medical cannabis so that one can tell the difference from other kinds of its use. Besides, the MEPs admitted that these researches should be funded, and the medical insurance should be covering the drugs based on this particular kind of cannabis.
Unlike the regular cannabis, the medical cannabis contains cannabinoids. It has no psychoactive effects, working as a painkiller and a sedative. Medical cannabis can be administered through a variety of methods, including capsules, lozenges, tinctures, dermal patches, oral or dermal sprays, cannabis edibles, and vaporizing or smoking dried buds. Synthetic cannabinoids are available for prescription use in some countries, such as dronabinol and nabilone.